Experienced in IgG4-Related Disease

Dr. Andrew D. Mccollum

Oncology | Internal Medicine
Baylor Scott & White Health
Texas Oncology, P.A.
3410 Worth Street, Suite 400, 
Dallas, TX 
Offers Telehealth
30 Years of Experience

Experienced in IgG4-Related Disease
Baylor Scott & White Health
Texas Oncology, P.A.
3410 Worth Street, Suite 400, 
Dallas, TX 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Andrew Mccollum is an Oncologist and an Internal Medicine provider in Dallas, Texas. Dr. Mccollum has been practicing medicine for over 30 years and is rated as an Experienced provider by MediFind in the treatment of IgG4-Related Disease. His top areas of expertise are Familial Colorectal Cancer, Pancreatic Cancer, Familial Pancreatic Cancer, and Colorectal Cancer.

His clinical research consists of co-authoring 1 peer reviewed article and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years.

Graduate Institution
University Of Texas Southwestern Medical School, 1995
Residency
Internal Medicine, Parkland Health & Hospital System
Specialties
Oncology
Internal Medicine
Licenses
Internal Medicine in TX
Board Certifications
American Board Of Internal Medicine
Fellowships
Hematology/Oncology, Dana Farber Cancer Institute
Hematology/Oncology, Brigham and Womens Hospital MA
Hematology/Oncology, Dana Farber Cancer Institute Yawkey
Hospital Affiliations
Baylor University Medical Center
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Arkansas Health and Wellness
  • PPO
Baylor Scott & White Health
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • OTHER COMMERCIAL
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
CareFirst
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Friday Health

Accepted plan types not found. Please verify directly with the provider.

Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Oscar
  • EPO
  • HMO
  • PPO
Scott and White Health
  • HMO
  • POS
Superior Health Plan
  • MANAGED MEDICAID PLAN
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 13 Less Insurance Carriers -

Locations

Texas Oncology, P.A.
3410 Worth Street, Suite 400, Dallas, TX 75246
Call: 972-449-0540
Other Locations
Baylor Scott & White Institute for Rehabilitation Dallas
909 N Washington Ave, Dallas, TX 75246
Call: 214-820-9300
Baylor University Medical Center, part of Baylor Scott & White Health
3500 Gaston Ave, Dallas, TX 75246
Call: 214-820-0111

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


3 Clinical Trials

Phase IB Trial of Induction Nivolumab or Nivolumab/Relatlimab Prior to Concurrent Chemoradiation in Patients With Operable Stage II/III Esophageal/ Gastroesophageal Junction Cancer
Phase IB Trial of Induction Nivolumab or Nivolumab/Relatlimab Prior to Concurrent Chemoradiation in Patients With Operable Stage II/III Esophageal/ Gastroesophageal Junction Cancer
Enrollment Status: Active_not_recruiting
Publish Date: March 06, 2025
Intervention Type: Drug, Radiation
Study Drugs: Nivolumab, Relatlimab, Carboplatin, Paclitaxel
Study Phase: Phase 1
REACTION (Radiation Enhanced Assessment of Combination Therapies in Immuno-ONcology) - Nivolumab or Nivolumab in Combination With Other Immuno-oncology (IO) Agents After Targeted Systemic Radiation in Patients With Advanced Esophagogastric Cancer
REACTION (Radiation Enhanced Assessment of Combination Therapies in Immuno-ONcology) - Nivolumab or Nivolumab in Combination With Other Immuno-oncology (IO) Agents After Targeted Systemic Radiation in Patients With Advanced Esophagogastric Cancer
Enrollment Status: Active_not_recruiting
Publish Date: December 11, 2024
Intervention Type: Drug
Study Phase: Phase 1/Phase 2
An International, Multicenter, Open-label, Randomized, Phase 3 Study of BLU-285 vs Regorafenib in Patients With Locally Advanced Unresectable or Metastatic Gastrointestinal Stromal Tumor (GIST)
An International, Multicenter, Open-label, Randomized, Phase 3 Study of BLU-285 vs Regorafenib in Patients With Locally Advanced Unresectable or Metastatic Gastrointestinal Stromal Tumor (GIST)
Enrollment Status: Completed
Publish Date: October 06, 2022
Intervention Type: Drug
Study Drugs: Avapritinib, Regorafenib
Study Phase: Phase 3
View 2 Less Clinical Trials

1 Total Publications

A phase II study with cetuximab and radiation therapy for patients with surgically resectable esophageal and GE junction carcinomas: Hoosier Oncology Group G05-92.
A phase II study with cetuximab and radiation therapy for patients with surgically resectable esophageal and GE junction carcinomas: Hoosier Oncology Group G05-92.
Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: October 03, 2013
Similar Doctors
Experienced in IgG4-Related Disease
Dr. Merrick H. Reese
Oncology | Hematology Oncology
Experienced in IgG4-Related Disease
Dr. Merrick H. Reese
Oncology | Hematology Oncology
12221 Merit Dr, #500, 
Dallas, TX 
 (8.7 miles away)
972-490-2900
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Merrick Reese is an Oncologist and a Hematologist Oncology provider in Dallas, Texas. Dr. Reese is rated as an Advanced provider by MediFind in the treatment of IgG4-Related Disease. His top areas of expertise are Angiosarcoma of the Scalp, Alveolar Soft Part Sarcoma, Undifferentiated Pleomorphic Sarcoma, and Mesenchymoma. Dr. Reese is currently accepting new patients.

Experienced in IgG4-Related Disease
Dr. Ina M. Patel
Hematology Oncology | Hematology | Oncology
Experienced in IgG4-Related Disease
Dr. Ina M. Patel
Hematology Oncology | Hematology | Oncology

University Of Texas Southwestern Medical Center At Dallas

6201 Harry Hines Blvd, 
Dallas, TX 
 (4.6 miles away)
214-633-5555
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Ina Patel is a Hematologist Oncology specialist and a Hematologist in Dallas, Texas. Dr. Patel is rated as an Advanced provider by MediFind in the treatment of IgG4-Related Disease. Her top areas of expertise are Paget Disease of the Breast, Breast Cancer, Inflammatory Breast Cancer, and Angiosarcoma.

Experienced in IgG4-Related Disease
Dr. Sandra L. Hofmann
Hematology Oncology | Hematology | Oncology
Experienced in IgG4-Related Disease
Dr. Sandra L. Hofmann
Hematology Oncology | Hematology | Oncology

University Of Texas Southwestern Medical Center At Dallas

5200 Harry Hines Blvd, 
Dallas, TX 
 (3.7 miles away)
214-590-8000
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Sandra Hofmann is a Hematologist Oncology specialist and a Hematologist in Dallas, Texas. Dr. Hofmann is rated as an Advanced provider by MediFind in the treatment of IgG4-Related Disease. Her top areas of expertise are Hemolytic-Uremic Syndrome, D-Plus Hemolytic Uremic Syndrome, Atypical Hemolytic Uremic Syndrome (aHUS), Bone Marrow Aspiration, and Splenectomy.

VIEW MORE IGG4-RELATED DISEASE DOCTORS

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Mccollum's expertise for a condition
ConditionClose
    • Distinguished
    • Familial Colorectal Cancer
      Dr. Mccollum is
      Distinguished
      . Learn about Familial Colorectal Cancer.
      See more Familial Colorectal Cancer experts
    • Familial Pancreatic Cancer
      Dr. Mccollum is
      Distinguished
      . Learn about Familial Pancreatic Cancer.
      See more Familial Pancreatic Cancer experts
    • Pancreatic Cancer
      Dr. Mccollum is
      Distinguished
      . Learn about Pancreatic Cancer.
      See more Pancreatic Cancer experts
    • Advanced
    • Anal Cancer
      Dr. Mccollum is
      Advanced
      . Learn about Anal Cancer.
      See more Anal Cancer experts
    • Colorectal Cancer
      Dr. Mccollum is
      Advanced
      . Learn about Colorectal Cancer.
      See more Colorectal Cancer experts
    • Gastroenteropancreatic Neuroendocrine Tumor (GEP-NET)
      Dr. Mccollum is
      Advanced
      . Learn about Gastroenteropancreatic Neuroendocrine Tumor (GEP-NET).
      See more Gastroenteropancreatic Neuroendocrine Tumor (GEP-NET) experts
    • Gastrointestinal Stromal Tumor
      Dr. Mccollum is
      Advanced
      . Learn about Gastrointestinal Stromal Tumor.
      See more Gastrointestinal Stromal Tumor experts
    • Lynch Syndrome
      Dr. Mccollum is
      Advanced
      . Learn about Lynch Syndrome.
      See more Lynch Syndrome experts
    • Neuroendocrine Tumor
      Dr. Mccollum is
      Advanced
      . Learn about Neuroendocrine Tumor.
      See more Neuroendocrine Tumor experts
    View All 7 Advanced Conditions
    • Experienced
    • Acute Myeloblastic Leukemia with Maturation
      Dr. Mccollum is
      Experienced
      . Learn about Acute Myeloblastic Leukemia with Maturation.
      See more Acute Myeloblastic Leukemia with Maturation experts
    • Acute Myeloblastic Leukemia without Maturation
      Dr. Mccollum is
      Experienced
      . Learn about Acute Myeloblastic Leukemia without Maturation.
      See more Acute Myeloblastic Leukemia without Maturation experts
    • Acute Myeloid Leukemia (AML)
      Dr. Mccollum is
      Experienced
      . Learn about Acute Myeloid Leukemia (AML).
      See more Acute Myeloid Leukemia (AML) experts
    • Adult Soft Tissue Sarcoma
      Dr. Mccollum is
      Experienced
      . Learn about Adult Soft Tissue Sarcoma.
      See more Adult Soft Tissue Sarcoma experts
    • Agranulocytosis
      Dr. Mccollum is
      Experienced
      . Learn about Agranulocytosis.
      See more Agranulocytosis experts
    • Appendix Cancer
      Dr. Mccollum is
      Experienced
      . Learn about Appendix Cancer.
      See more Appendix Cancer experts
    View All 51 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile
    For Patients
    • Our Story
    • How MediFind Works
    • Conditions A-Z
    • Doctor Directory
    • Symptoms Directory
    • Procedures Directory
    • Treatment Directory
    • Drug Directory
    • Infusion Center Finder
    • FAQ
    • Contact Us
    For Providers and Practices
    • Claim Your Profile
    • Newsroom
    Business Solutions
    • Provider
    • Network Solutions
    Additional Resources
    • Consumer Health Data Privacy Policy
    • Privacy Policy
    • Terms of Use
    • Advertising Policy
    • Content Policy
    Subscribe to our newsletter

    Sign up to stay informed about MediFind and get wellness sent your way.

    Close

      By subscribing, I agree to MediFind's Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.

      Bullet PinMediFind
      Follow us on
      This information is not intended as a substitute for informed medical advice. You should work with a licensed professional to diagnose and treat health conditions. We let the data speak for itself, MediFind does not endorse any healthcare providers.
      © 2025 All Rights Reserved